BUZZ-Hoth Therapeutics rises as AI used to speed rare cancer drug development
Reuters03-04
BUZZ-<a href="https://laohu8.com/S/HOTH">Hoth Therapeutics</a> rises as AI used to speed rare cancer drug development
** Shares of Hoth TherapeuticsHOTH.O rise 4.33% to $1.04 premarket
** Co says it is using OpenAI tools to help develop drug for rare cancers caused by faulty KIT gene, which can drive tumor growth
** Co says early tests of its experimental drug, HT-KIT, sharply lowered KIT gene levels in lab and animal studies, with no serious side effects
** HOTH's HT-KIT also led to tumor shrinkage in animals within just over a week, co says
** Co preparing to seek U.S. approval to begin human testing; drug has orphan status
** Shares up ~32% in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments